SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-012782
Filing Date
2022-05-11
Accepted
2022-05-11 08:30:33
Documents
57
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 749778
2 ex31-1.htm EX-31.1 8044
3 ex31-2.htm EX-31.2 8044
4 ex31-3.htm EX-31.3 7945
5 ex32-1.htm EX-32.1 6236
  Complete submission text file 0001493152-22-012782.txt   4127748

Data Files

Seq Description Document Type Size
6 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cocp-20220331.xsd EX-101.SCH 32372
7 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cocp-20220331_cal.xml EX-101.CAL 44488
8 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cocp-20220331_def.xml EX-101.DEF 124414
9 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cocp-20220331_lab.xml EX-101.LAB 278879
10 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cocp-20220331_pre.xml EX-101.PRE 217358
51 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 663443
Mailing Address 19805 N. CREEK PARKWAY BOTHELL WA 98011
Business Address 19805 N. CREEK PARKWAY BOTHELL WA 98011 (786) 459-1831
Cocrystal Pharma, Inc. (Filer) CIK: 0001412486 (see all company filings)

IRS No.: 352528215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38418 | Film No.: 22912178
SIC: 2834 Pharmaceutical Preparations